Animal Models for Hepatitis B Infections — Duck Hepatitis

[1]  S. Locarnini,et al.  Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro , 1997, Hepatology.

[2]  M. Rashidi,et al.  In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[3]  F. Zoulim,et al.  Inhibitory Effect of Penciclovir-Triphosphate on Duck Hepatitis B Virus Reverse Transcription , 1997 .

[4]  P. Angus,et al.  Demonstration of duck hepatitis B virus in bile duct epithelial cells: Implications for pathogenesis and persistent infection , 1997, Hepatology.

[5]  D. Miller,et al.  Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. , 1996, Virology.

[6]  T. Shaw,et al.  Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir , 1996, Hepatology.

[7]  Y. Cossart,et al.  DHBV manipulation and prediction of the outcome of infection. , 1996, Journal of hepatology.

[8]  S. Locarnini,et al.  Long‐term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: Effect on intrahepatic‐viral DNA, RNA, and protein expression , 1996, Hepatology.

[9]  H. Schlicht,et al.  Uptake of duck hepatitis B virus into hepatocytes occurs by endocytosis but does not require passage of the virus through an acidic intracellular compartment , 1996, Journal of virology.

[10]  H. Schaller,et al.  Hepatitis B virus replication‐an update , 1996, Journal of viral hepatitis.

[11]  F. von Weizsäcker,et al.  Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein , 1996, Hepatology.

[12]  H. Blum,et al.  Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo , 1996, Hepatology.

[13]  M. Buendia,et al.  A new hepadnavirus endemic in arctic ground squirrels in Alaska , 1996, Journal of virology.

[14]  H. Thomas,et al.  A double blind, placebo‐controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection , 1996, Journal of viral hepatitis.

[15]  B. Korba,et al.  Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells , 1996, Antimicrobial agents and chemotherapy.

[16]  S. Locarnini,et al.  Interaction between ganciclovir and foscarnet as inhibitors of duck hepatitis B virus replication in vitro , 1996, Antimicrobial agents and chemotherapy.

[17]  C. Rogler,et al.  Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells , 1996, Journal of virology.

[18]  H. Blum,et al.  Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo , 1996, Antimicrobial agents and chemotherapy.

[19]  O. Yokosuka,et al.  Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings. , 1996, Journal of hepatology.

[20]  F. Zoulim,et al.  2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo , 1996, Antimicrobial agents and chemotherapy.

[21]  S. Locarnini,et al.  The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo , 1996, Antimicrobial agents and chemotherapy.

[22]  M. J. Robins,et al.  Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2′,3′‐dideoxyguanosine 5′‐triphosphate to the viral polymerase , 1996, Hepatology.

[23]  E. Keeffe,et al.  Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients , 1996, Hepatology.

[24]  S. Locarnini,et al.  Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis. , 2008, Liver.

[25]  H. Schlicht,et al.  Recombinant duck interferon: a new reagent for studying the mode of interferon action against hepatitis B virus. , 1995, Virology.

[26]  J. Newbold,et al.  Detection of an RNase H activity associated with hepadnaviruses , 1995, Journal of virology.

[27]  H. Simmons,et al.  Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles , 1995, Journal of virology.

[28]  D. Tyrrell,et al.  Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-beta-L-2',3'-dideoxy-3'-thiacytidine , 1995, Antimicrobial agents and chemotherapy.

[29]  S. Locarnini,et al.  The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes , 1995, Journal of virology.

[30]  S. Locarnini,et al.  Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir. , 1995, Antiviral research.

[31]  S. Locarnini,et al.  Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid , 1995, Antimicrobial agents and chemotherapy.

[32]  S. Locarnini,et al.  Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. , 2008, Liver.

[33]  J. Colacino,et al.  Priming of duck hepatitis B virus reverse transcription in vitro: premature termination of primer DNA induced by the 5'-triphosphate of fialuridine , 1994, Journal of virology.

[34]  E. De Clercq,et al.  Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture , 1994, Antimicrobial Agents and Chemotherapy.

[35]  P. Marion,et al.  Selected mutations of the duck hepatitis B virus P gene RNase H domain affect both RNA packaging and priming of minus-strand DNA synthesis , 1994, Journal of virology.

[36]  J. Summers,et al.  Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus , 1994, Journal of virology.

[37]  S. Ida,et al.  In vivo antiviral effects of mismatched double‐stranded RNA on duck hepatitis B virus , 1994, Journal of medical virology.

[38]  J. Pollack,et al.  Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. , 1994, Infectious agents and disease.

[39]  S. Locarnini,et al.  In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus , 1994, Antimicrobial Agents and Chemotherapy.

[40]  K. Tsiquaye,et al.  Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo , 1994, Journal of medical virology.

[41]  Tsung-Teh Wu,et al.  Characterization of the antiviral effects of 2′ carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus , 1994, Hepatology.

[42]  J. Gerdes,et al.  An examination of the immune system of the duck (Anas platyrhynchos) for factors resembling some defined mammalian cytokines. , 1993, Developmental and comparative immunology.

[43]  H. Blum,et al.  Suramin prevents duck hepatitis B virus infection in vivo , 1993, Antimicrobial Agents and Chemotherapy.

[44]  E. De Clercq,et al.  Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. , 1993, Antiviral research.

[45]  S. Locarnini,et al.  The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus. , 1993, Antiviral research.

[46]  D. Ganem,et al.  Inhibition of duck hepatitis B virus replication by interferon‐γ , 1993, Journal of medical virology.

[47]  S. Panda,et al.  Evaluation of Phyllanthus amarus and Phyllanthus maderaspatensis as agents for postexposure prophylaxis in neonatal duck hepatitis B virus infection , 1993, Journal of medical virology.

[48]  H. Blum,et al.  In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. , 1993, The EMBO journal.

[49]  T. Wu,et al.  Inhibition of duck hepatitis B virus replication by hypericin. , 1993, Antiviral research.

[50]  C. Seeger,et al.  The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis , 1992, Cell.

[51]  T. Wu,et al.  Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement , 1992, Journal of virology.

[52]  R. Sprengel,et al.  Characterization of infectious and defective cloned avian hepadnavirus genomes. , 1991, Virology.

[53]  T. Halbherr,et al.  A technique for liver biopsy performed in Pekin ducks using anesthesia with Telazol. , 1991, Laboratory animal science.

[54]  D. Lorne,et al.  Inhibition of duck hepatitis B virus replication in vitro by 2',3'-dideoxy-3'-azidothymidine and related compounds. , 1991, Acta virologica.

[55]  S. Bowden,et al.  Inhibition of Duck Hepatitis B Virus Replication in vivo by the Nucleoside Analogue Ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] Guanine) , 1991 .

[56]  S. Locarnini,et al.  Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo , 1990, Journal of medical virology.

[57]  Shinobu,et al.  Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro , 1990, Antimicrobial Agents and Chemotherapy.

[58]  T. Wu,et al.  Efficient duck hepatitis B virus production by an avian liver tumor cell line , 1990, Journal of virology.

[59]  J. Cullen,et al.  Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks. , 1990, Cancer research.

[60]  I. Gust,et al.  Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds , 1990, Journal of medical virology.

[61]  J. Summers,et al.  In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. , 1990, Virology.

[62]  K. Furtak,et al.  Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultured HuH7 cells , 1990, Journal of virology.

[63]  G. Radziwill,et al.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity , 1990, Journal of virology.

[64]  D. A. Higgins.  Duck lymphocytes--III. Transformation responses to some common mitogens. , 1990, Comparative immunology, microbiology and infectious diseases.

[65]  T. Shikata,et al.  Effect of 3′‐azido‐3′‐deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro , 1989, Journal of medical virology.

[66]  S. Locarnini,et al.  INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDS , 1989, The Lancet.

[67]  T. Gojobori,et al.  Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[68]  D. Tyrrell,et al.  Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides. , 1988, Biochemical and biophysical research communications.

[69]  Y. Cossart,et al.  Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. , 1988, Gastroenterology.

[70]  R. Sprengel,et al.  Isolation and characterization of a hepatitis B virus endemic in herons , 1988, Journal of virology.

[71]  K. Dörries,et al.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS , 1988, Journal of virology.

[72]  R. Sprengel,et al.  Duck Hepatitis B Virus , 1988 .

[73]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[74]  J. W. Campbell,et al.  Uricoteley:its nature and origin during the evolution of tetrapod vertebrates. , 1987, The Journal of experimental zoology.

[75]  J. Cullen,et al.  Experimental transmission of duck hepatitis B virus to pekin ducks and to domestic geese , 1987, Hepatology.

[76]  D. Davis.  Duck hepatitis virus: adaptation of a plaque assay to determine 50 per cent end points with duck sera. , 1987, Research in Veterinary Science.

[77]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[78]  Freiman Js,et al.  Natural duck hepatitis B virus infection in Australia. , 1986 .

[79]  A. Zuckerman,et al.  Antiviral activity of the polybasic anion, suramin and acyclovir in Hepadna virus infection. , 1986, The Journal of antimicrobial chemotherapy.

[80]  J. Summers,et al.  In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus , 1986, Journal of virology.

[81]  T. Halbherr,et al.  A newly identified hepatitis B type virus in tree squirrels. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[82]  L. Cova,et al.  Evidence for the presence of duck hepatitis B virus in wild migrating ducks. , 1986, The Journal of general virology.

[83]  O. Yokosuka,et al.  In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver. Resistance of supercoiled viral DNA. , 1986, Journal of hepatology.

[84]  O. Yokosuka,et al.  Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA , 1985, Hepatology.

[85]  A. Zuckerman,et al.  Maternal transmission of duck hepatitis B virus in pedigree pekin ducks , 1985, Hepatology.

[86]  A. Zuckerman,et al.  Experimental in ovo transmission of duck hepatitis B virus. , 1985, Journal of virological methods.

[87]  R. Sprengel,et al.  Cloned duck hepatitis B virus DNA is infectious in Pekin ducks , 1984, Journal of virology.

[88]  F. Galibert,et al.  Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences , 1984, Journal of virology.

[89]  P. Marion,et al.  Liver disease associated with duck hepatitis B virus infection of domestic ducks. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Summers,et al.  Experimental transmission of duck hepatitis B virus. , 1983, Virology.

[91]  P. Marion,et al.  The nature of polypeptides larger in size than the major surface antigen components of hepatitis b and like viruses in ground squirrels, woodchucks, and ducks. , 1983, Virology.

[92]  O. Yokosuka,et al.  Duck hepatitis B virus and liver diseases. , 1983, Gastroenterology.

[93]  K. Molnar-Kimber,et al.  Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[94]  J. Summers,et al.  Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate , 1982, Cell.

[95]  J. Gerin,et al.  Surface antigenic determinants of mammalian "hepadnaviruses" defined by group- and class-specific monoclonal antibodies , 1982, Journal of virology.

[96]  J. Summers,et al.  Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus , 1980, Journal of virology.

[97]  P. Marion,et al.  A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Summers,et al.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Evans Jw.  SPECIAL" CALLS IN GENERAL PRACTICE. , 1963 .